M. Zabka - Selvita integrated drug discovery collaborations
by Klaster LifeScience Kraków on Oct 17, 2011
- 574 views
Selvita aims to provide outstanding customer service and maintain commitment to scientific excellence through best-in-class products, services, and procedures....
Selvita aims to provide outstanding customer service and maintain commitment to scientific excellence through best-in-class products, services, and procedures.
Products and services highlight:
Selvita Group has experience in several areas of life sciences and offers the following types of projects:
- Integrated drug discovery projects which include in silico drug design, and synthesis of a target-focused library, SAR and ADME-driven lead optimization and toxicity prediction, followed by complex preclinical in vitro development.
- Chemistry services, including contract synthesis, synthesis pathway design and optimization, synthesis scale-up, physicochemical analyses including stability studies and impurity profiles, as well as drug form development support.
- Biology services, including assay development, ADME and toxicity studies, DMPK studies as well as pharmacokinetic and pharmacodynamics analyses
- Advanced protein modeling solutions, based on our proprietary protein modeling platform, virtual screening and focused library design, as well as other services in computational chemistry.
As a showcase of its capability and interesting co-development opportunity, Selvita Group also runs several internal drug discovery projects, the most advanced ones being in oncology and in CNS.
Selvita' Group laboratories are certified with the Good Laboratory Practice (GLP) certificate, as well as have the accreditation of Polish General Pharmaceutical Inspectorate.
- Total Views
- Views on SlideShare
- Embed Views